Endocrine and Diabetes Biomarkers

A biomarker is any substance, structure, or process that should be measurable in the body or its products and it also influences or predicts the incidence of outcome or disease. For predicting type 1 diabetes, a biomarker should be present in a subset of the population, and this subset should have an influence on the proportion of people in whom this type 1 diabetes develops. A biomarker should also present a significant risk for the development of type 1 diabetes within a defined period of time or diagnose a “stage” in the progression to clinical or symptomatic type1 diabetes. As described in this article, most of the biomarkers are  used for the prediction of type 1 diabetes are islet-specific supporting the concept that, before overt hyperglycaemia, type 1 diabetes is generally predominantly a targeted disease rather than a systemic disease.

Atomic Biomarkers can be separated as a trademark that is precisely measured and gaged as a pointer of typical natural methods, pathogenic methodology, or pharmacologic reactions to a pharmaceutical intercession.

Biomarkers have fundamental influences in driving clinical trials and treating the patients. Progress in sub-atomic diagnostics helps medicinal experts make proficient, experimentally legitimate choices. All the more efficient disclosure and use of biomarkers in the development of ant diabetes medications will rely on upon quickening our comprehension of the pathogenesis of diabetes and particularly its macro vascular entanglements. Procedural upgrades in different fields, particularly tumour, are started to demonstrate the way towards the better models of diabetes pathogenesis and atomic biomarker revelation.

 

  • Prognostic marker
  • Diabetic nephropathy marker
  • Molecular marker for metabolic syndrome
  • Molecular Marker-Hypoglycaemic response
  • Inflammatory markers: Type 2 diabetes

Related Conference of Endocrine and Diabetes Biomarkers

March 25-26, 2024

5th Annual Conference on Diabetes

London, UK
July 11-12, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Endocrine and Diabetes Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in